US 12,227,483 B1
Amino acid compositions
Ronald Kramer, Signal Hill, CA (US); and Alexandros Nikolaidis, Nea Kallikratia (GR)
Assigned to ThermoLife International, LLC, Signal Hill, CA (US)
Filed by ThermoLife International, LLC, Signal Hill, CA (US)
Filed on Nov. 9, 2021, as Appl. No. 17/522,680.
Application 17/522,680 is a division of application No. 14/621,738, filed on Feb. 13, 2015, granted, now 11,166,979.
Application 14/621,738 is a continuation of application No. 13/920,066, filed on Jun. 17, 2013, granted, now 8,957,100, issued on Feb. 17, 2015.
Application 13/920,066 is a continuation of application No. 13/038,615, filed on Mar. 2, 2011, granted, now 8,466,187, issued on Jun. 18, 2013.
Application 13/038,615 is a continuation in part of application No. 12/336,938, filed on Dec. 17, 2008, granted, now 8,034,836, issued on Oct. 11, 2011.
Application 12/336,938 is a continuation of application No. 11/950,273, filed on Dec. 4, 2007, granted, now 7,777,074, issued on Aug. 17, 2010.
Claims priority of provisional application 60/973,229, filed on Sep. 18, 2007.
This patent is subject to a terminal disclaimer.
Int. Cl. C07C 229/08 (2006.01); A61K 31/185 (2006.01); A61K 31/197 (2006.01); A61K 31/198 (2006.01); A61K 31/205 (2006.01); A61K 31/221 (2006.01); A61K 31/401 (2006.01); A61K 31/4172 (2006.01); A61K 33/00 (2006.01); C07C 229/24 (2006.01); C07C 229/26 (2006.01); C07C 237/06 (2006.01); C07C 275/16 (2006.01); C07C 279/02 (2006.01); C07C 323/58 (2006.01); C07D 207/16 (2006.01); C07D 233/64 (2006.01)
CPC C07D 233/64 (2013.01) [A61K 31/185 (2013.01); A61K 31/197 (2013.01); A61K 31/198 (2013.01); A61K 31/205 (2013.01); A61K 31/221 (2013.01); A61K 31/401 (2013.01); A61K 31/4172 (2013.01); A61K 33/00 (2013.01); C07C 229/08 (2013.01); C07C 229/24 (2013.01); C07C 229/26 (2013.01); C07C 237/06 (2013.01); C07C 275/16 (2013.01); C07C 279/02 (2013.01); C07C 323/58 (2013.01); C07D 207/16 (2013.01)] 6 Claims
 
1. A method of increasing the bioabsorption of a compound in a human comprising:
administering to the human an effective amount of a composition or a supplement formulation, the composition or supplement formulation comprising:
the compound, wherein the compound is selected from the group consisting of: Carnitine, Taurine, and derivative forms thereof; and
a Nitrate, wherein the Nitrate is selected from the group consisting of: a vegetable source of nitrate, sodium nitrate, potassium nitrate, calcium nitrate, and a mixed salt of nitrate.